It binds to glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors hormones that stimulate insulin secretion and suppress appetite
Keywords: immune checkpoint inhibitors, adverse events, anti-PD-1, anti-PD-L1, anti-CTLA-4, efficacy, survival, correlation Correspondence to: Omar Abdihamid Email: [email protected] Published: 02/11/2021 Received: 07/03/2021 Publication costs for this article were supported by e cancer (UK Charity number 1176307)
If more than five days have passed, skip that dose and stick to your usual schedule
Cook CA, Lund BA, Carney JA
However, translation to human therapies requires rigorous clinical trials to establish safety and efficacy